In addition, a number of studies have confirmed that UBE2T plays a carcinogenic role in a variety of cancers, including lung cancer, gastric cancer, renal cell carcinoma, osteosarcoma, prostate cancer and glioma [24–29]. This evidence concerns the gene UBE2T and hereditary clear cell renal cell carcinoma.